EUVIMEDEUVIMED entdecken
Crossref

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions

Cesar Torres iD, Gregory Levin iD, Daniel Rubin, William Koh, Rebecca Chiu iD, Thomas Permutt

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.70002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Cesar Torres und 5 weiteren Autor:innen. Beteiligte Einrichtung: Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design, Models, Statistical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is critical to evaluate the sensitivity of conclusions from a clinical trial to potential violations in the missing data assumptions of the statistical analysis. Sensitivity analyses should not consist of a few methods that might have been reasonable alternatives to the chosen analysis method, nor should they explore only a limited space of violations in the assumptions of the analysis. Instead, sensitivity analyses should target the same estimand as that targeted in the main analysis, and they should systematically and comprehensively explore the space of possible assumptions to evaluate whether the key conclusions hold up under all plausible scenarios. In a randomized, controlled trial, this can be achieved by tipping point analyses that vary assumptions about missing outcomes on the experimental and control arms to identify and discuss the plausibility of scenarios under which there is no longer evidence of a treatment effect. We introduce a simple, novel tipping point approach in which, for a variable that is quantitative or can be analyzed as if it is quantitative, inference on the treatment effect is based on the observed data and two sensitivity parameters, with minimal assumptions and no need for imputation. The sensitivity parameters to be varied are the mean differences between outcomes in dropouts and outcomes in completers on each of the two treatment arms. We derive the asymptotic properties of the proposed statistic and illustrate the utility of such an approach with two examples of drug reviews in which the methodology was utilized to inform regulatory decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignModels, StatisticalHumansData Interpretation, Statistical

Stichwörter der Autor:innen

clinical trialsmissing datasensitivity analysistipping point

Autor:innen und Institutionen

  • Food and Drug Administration, Silver Spring, Maryland, USA.
  • retired.

ORCID-Profile: Cesar Torres, Gregory Levin, Rebecca Chiu

Zitieren

APA

Torres, C., Levin, G., Rubin, D., Koh, W., Chiu, R., & Permutt, T. (2025). A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70002

Vancouver

Torres C, Levin G, Rubin D, Koh W, Chiu R, Permutt T. A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions. Pharmaceutical Statistics. 2025. doi:10.1002/pst.70002

BibTeX
@article{Torres2025,
  author = {Torres, Cesar and Levin, Gregory and Rubin, Daniel and Koh, William and Chiu, Rebecca and Permutt, Thomas},
  title = {A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.70002}
}
Kostenlos starten →